🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Completed
Location
ICON Early Phase Services
Start Date
2022-04-26
Trial ID
NCT05334108
The study is being conducted to assess the effect of BMS-986142 on the sing...
Status
Completed
Location
Ppd Development, Lp
Start Date
2016-05
Trial ID
NCT02762123
The purpose of this study is to evaluate the safety, efficacy and pharmacok...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-07-31
Trial ID
NCT05967689
Treatments Being Tested
This is a Phase 1, open-label, 3-period study to determine radiprodil's pot...
Status
Completed
Location
Nucleus Network Melbourne
Start Date
2025-05-20
Trial ID
NCT06975605
Treatments Being Tested
This study will assess safety, tolerability and pharmacokinetic (PK) of VH3...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2024-08-02
Trial ID
NCT06533280
The purpose of this study is to look at how much lasmiditan, study drug, ge...
Status
Completed
Location
Covance Daytona Beach
Start Date
2017-08-15
Trial ID
NCT03252015
Treatments Being Tested
Primary Objective: To assess the effect of repeated once-daily oral doses ...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2016-10
Trial ID
NCT02940379
Treatments Being Tested
The main objective of this study is to assess the effect of DC-806 on the p...
Status
Completed
Location
ICON Phase 1 Clinic
Start Date
2023-10-16
Trial ID
NCT06092931
Treatments Being Tested
The purpose of this study is to assess the effect of multiple doses of gana...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-09
Trial ID
NCT05236530